ADMA logo

ADMA Biologics (ADMA)

Profile

Full Name

ADMA Biologics, Inc.

Ticker Symbol

ADMA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 17, 2013

Indexes

Not included

Website

http://www.admabiologics.com

Employees

685

Key Details

Price

$20.91(+7.78%)

Market cap

$4.97B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$426.45M(+65.15% YoY)

Annual EPS

$0.81(+723.08% YoY)

PE ratio

25.50

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$20.91
ADMA price is $20.91

30-Day Relative Volume

1.88
ADMA 30-day relative volume is 1.88

Price Performance

Price Most recent change

+7.78%
ADMA price was up +7.78% on Apr 14, 2025

Price YTD change

+21.92%
ADMA price is up +21.92% since January 1st

Price 1-year change

+247.34%
ADMA price is up +247.34% year-on-year

Price 3-year change

+940.3%
ADMA price is up +940.3% over the past 3 years

Price Range

Price All-time high

$23.64
ADMA price is currently -11.55% below its historical high of $23.64

Price 3-year low

$1.43
ADMA price is currently +1362.24% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.97B
ADMA market capitalization is $4.97 billion

Market cap 3-year change

+1158.94%
ADMA market capitalization is up +1158.94% over the past 3 years

Market cap All-time high

$5.41B
ADMA market capitalization is currently -8.22% below its historical high of $5.41 billion

Market cap sector rank

89.15%
ADMA market capitalization is higher than 89.15% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.52%
ADMA shares outstanding is up +2.52% year-on-year

Shares Outstanding 3-Year Change

+21.02%
ADMA shares outstanding is up +21.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.26
ADMA beta is 1.26

200-day SMA

$17.25
ADMA price is currently +21.19% above its 200-day simple moving average

50-day SMA

$17.80
ADMA price is currently +17.47% above its 50-day simple moving average

RSI

60.87
ADMA 14-day relative strength index is 60.87

Volume

1.88
ADMA 30-day relative volume is 1.88

ATR

$1.39
ADMA average true range is $1.39

10-day Historical Volatility

85.77%
ADMA 10-day historical volatility is 85.77%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$426.45M
ADMA annual revenue is $426.45 million

Revenue Analysts estimate

$495.23M
ADMA annual revenue is currently -13.89% lower than the consensus analysts' forecast

Revenue 1-year change

+65.15%
ADMA annual revenue is up +65.15% year-on-year

Revenue Sector rank

72.56%
ADMA annual revenue is higher than 72.56% of companies in Healthcare sector

EPS

EPS

$0.81
ADMA annual earnings per share is $0.81

EPS Analysts estimate

$0.71
ADMA annual earnings per share is currently +14.08% higher than the consensus analysts' forecast

EPS 1-year change

+723.08%
ADMA annual earnings per share is up +723.08% year-on-year

EPS Sector rank

88.67%
ADMA annual earnings per share is higher than 88.67% of companies in Healthcare sector

Profit

Gross profit

$219.55M
ADMA annual gross profit is $219.55 million

Gross margin

51.48%
ADMA annual gross profit margin is 51.48%

Operating profit

$138.98M
ADMA annual operating income is $138.98 million

Operating margin

32.59%
ADMA annual operating profit margin is 32.59%

Net income

$197.67M
ADMA annual net profit is $197.67 million

Net margin

46.35%
ADMA annual net profit margin is 46.35%

Expenses

Total expenses

$287.47M
ADMA annual total expenses is $287.47 million

Operating expenses

$80.57M
ADMA annual total operating expenses is $80.57 million

Cost of goods sold

$206.90M
ADMA annual cost of goods sold is $206.90 million

Selling, general & administrative expenses

$74.12M
ADMA annual SGA is $74.12 million

Depreciation and amortization

$8.04M
ADMA annual depreciation & amortization is $8.04 million

Interest expense

$13.93M
ADMA annual interest expense is $13.93 million

Income tax

-$71.96M
ADMA annual income tax is -$71.96 million

EBIT & EBITDA

EBIT

$139.64M
ADMA annual earnings before interest & taxes is $139.64 million

EBITDA

$140.03M
ADMA annual EBITDA is $140.03 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$488.68M
ADMA annual total assets is $488.68 million

Non current assets

$157.27M
ADMA annual long term assets is $157.27 million

Current assets

$331.41M
ADMA annual total current assets is $331.41 million

Cash and cash equivalents

$103.15M
ADMA annual cash & cash equivalents is $103.15 million

Accounts receivable

$50.00M
ADMA annual accounts receivable is $50.00 million

Inventory

$170.24M
ADMA annual inventory is $170.24 million

Liabilities

Total liabilities

$139.66M
ADMA annual total liabilities is $139.66 million

Long term liabilities

$84.12M
ADMA annual total long term liabilities is $84.12 million

Current liabilities

$55.54M
ADMA annual total current liabilities is $55.54 million

Accounts payable

$20.22M
ADMA annual accounts payable is $20.22 million

Debt

Total debt

$82.12M
ADMA annual total debt is $82.12 million

Total debt 1-year change

-41.93%
ADMA annual total debt is down -41.93% year-on-year

Long term debt

$80.90M
ADMA annual long term debt is $80.90 million

Short term debt

$1.22M
ADMA annual short term debt is $1.22 million

Equity & Capital

Shareholders equity

$349.02M
ADMA annual stockholders equity is $349.02 million

Book value

$349.02M
ADMA annual book value is $349.02 million

Retained earnings

-$308.58M
ADMA annual retained earnings is -$308.58 million

Working capital

$275.87M
ADMA annual working capital is $275.87 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$118.67M
ADMA annual cash flow from operations is $118.67 million

Cash from operations 1-year change

+1248.55%
ADMA annual cash flow from operations is up +1248.55% year-on-year

Cash from investing

-$8.57M
ADMA annual cash flow from investing activities is -$8.57 million

Cash from investing 1-year change

-72.15%
ADMA annual cash flow from investing activities is down -72.15% year-on-year

Cash from financing

-$58.30M
ADMA annual cash flow from financing activities is -$58.30 million

Cash from financing 1-year change

-49.53%
ADMA annual cash flow from financing activities is down -49.53% year-on-year

CAPEX

CAPEX

$8.57M
ADMA annual capital expenditures is $8.57 million

CAPEX 1-year change

+72.15%
ADMA annual capital expenditures is up +72.15% year-on-year

Free Cash Flow

Free cash flow

$110.10M
ADMA annual free cash flow is $110.10 million

Free cash flow 1-year change

+2782.88%
ADMA annual free cash flow is up +2782.88% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

51.48%
ADMA annual gross profit margin is 51.48%

Operating margin

32.59%
ADMA annual operating profit margin is 32.59%

Net margin

46.35%
ADMA annual net profit margin is 46.35%

ROA & ROE

ROA

48.34%
ADMA annual return on assets is 48.34%

ROE

81.65%
ADMA annual return on equity is 81.65%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

25.50
ADMA price to earnings ratio is 25.50

PE ratio Sector rank

52.45%
ADMA price to earnings ratio is higher than 52.45% of companies in Healthcare sector

PB Ratio

PB ratio

14.24
ADMA price to book ratio is 14.24

PB ratio Sector rank

95.48%
ADMA price to book ratio is higher than 95.48% of companies in Healthcare sector

PS Ratio

PS ratio

11.65
ADMA price to sales ratio is 11.65

PS ratio Sector rank

81.41%
ADMA price to sales ratio is higher than 81.41% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.95B
ADMA enterprise value is $4.95 billion

Enterprise value Sector rank

88.03%
ADMA enterprise value is higher than 88.03% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

33.94
ADMA EV/EBITDA is 33.94

EV/EBITDA Sector rank

95.57%
ADMA EV/EBITDA is higher than 95.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.97
ADMA annual current ratio is 5.97

Quick ratio

2.90
ADMA annual quick ratio is 2.90

Leverage

Debt to equity

0.21
ADMA annual debt to equity ratio is 0.21

Interest coverage ratio

10.02
ADMA annual interest coverage ratio is 10.02

Risk & Stability

Piotroski F-Score

7
ADMA piotroski f-score is 7

Altman Z-Score

22.95
ADMA altman z-score is 22.95

Analyst ratings

Recent major analysts updates

Mar 4, 25 Cantor Fitzgerald
Overweight
Nov 8, 24 Raymond James
Strong Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 14, 24 HC Wainwright & Co.
Buy
Sep 20, 24 Cantor Fitzgerald
Overweight
Aug 12, 24 HC Wainwright & Co.
Buy
Aug 9, 24 Cantor Fitzgerald
Overweight
Jul 9, 24 Cantor Fitzgerald
Overweight
Jun 20, 24 Mizuho
Buy
May 10, 24 Raymond James
Strong Buy

Institutional Ownership

Similar stocks

NUVL logo
Nuvalent (NUVL)
VRNA logo
Verona Pharma (VRNA)
AXSM logo
Axsome Therapeutics (AXSM)
KRYS logo
Krystal Biotech (KRYS)
GRFS logo
Grifols SA (GRFS)
CYTK logo
Cytokinetics Incorporated (CYTK)
GKOS logo
Glaukos (GKOS)
OPCH logo
Option Care Health (OPCH)
BPMC logo
Blueprint Medicines (BPMC)
  • What is the ticker symbol for ADMA Biologics?
  • Does ADMA Biologics pay dividends?
  • What sector is ADMA Biologics in?
  • What industry is ADMA Biologics in?
  • What country is ADMA Biologics based in?
  • When did ADMA Biologics go public?
  • Is ADMA Biologics in the S&P 500?
  • Is ADMA Biologics in the NASDAQ 100?
  • Is ADMA Biologics in the Dow Jones?
  • When was ADMA Biologics's last earnings report?
  • When does ADMA Biologics report earnings?
  • Should I buy ADMA Biologics stock now?

What is the ticker symbol for ADMA Biologics?

The ticker symbol for ADMA Biologics is NASDAQ:ADMA

Does ADMA Biologics pay dividends?

No, ADMA Biologics does not pay dividends

What sector is ADMA Biologics in?

ADMA Biologics is in the Healthcare sector

What industry is ADMA Biologics in?

ADMA Biologics is in the Biotechnology industry

What country is ADMA Biologics based in?

ADMA Biologics is headquartered in United States

When did ADMA Biologics go public?

ADMA Biologics's initial public offering (IPO) was on October 17, 2013

Is ADMA Biologics in the S&P 500?

No, ADMA Biologics is not included in the S&P 500 index

Is ADMA Biologics in the NASDAQ 100?

No, ADMA Biologics is not included in the NASDAQ 100 index

Is ADMA Biologics in the Dow Jones?

No, ADMA Biologics is not included in the Dow Jones index

When was ADMA Biologics's last earnings report?

ADMA Biologics's most recent earnings report was on Mar 3, 2025

When does ADMA Biologics report earnings?

The next expected earnings date for ADMA Biologics is May 9, 2025

Should I buy ADMA Biologics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page